Abstract
BACKGROUND In many jurisdictions public health authorities have implemented travel restrictions to reduce coronavirus disease 2019 (COVID-19) spread. Previous research has considered the impact of international travel restrictions on COVID-19 dynamics, but in response to the pandemic, policies that restrict travel within countries have also been implemented, and the impact of these restrictions is less well studied. On May 4th, 2020, Newfoundland and Labrador (NL) implemented travel restrictions such that non-residents were required to have exemptions to enter the province.
METHODS We fit a stochastic epidemic model to data describing the number of active COVID-19 cases in NL from March 14th – May 4th. We then predicted possible outbreaks over the 9 weeks subsequent to May 4th, with and without the travel restrictions, and for physical distancing scenarios ranging from a 40% to 70% reduction in the daily contact rate relative to pre-pandemic levels. RESULTS: We find that the mean number of clinical COVID-19 cases would have been 12.4 times higher without the travel restrictions. Furthermore, without the travel restrictions there is a substantial risk of very large outbreaks.
INTERPRETATION Using epidemic modelling, we show how the NL COVID-19 outbreak could have unfolded had the travel restrictions not been implemented. Both physical distancing and travel restrictions affect the local dynamics of the epidemic. Our modelling shows that the travel restrictions are a plausible reason why there were so few reported COVID-19 cases in NL in the 9 weeks after May 4th.
Competing Interest Statement
All authors are members of the Predictive Analytics team assembled by the Newfoundland and Labrador Center for Health Information to provide mathematical modelling support to the province of Newfoundland and Labrador. This manuscript arises from a technical report that was prepared at the request of the Department of Justice and Public Safety, Newfoundland and Labrador. This study was not influenced by any representatives of Newfoundland and Labrador.
Funding Statement
AH was supported by funding from the AARMS Center for Disease Modelling.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study considers only publicly available data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data and code are archived on FigShare.
